Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 263

1.

Overexpression of miR‑221 and miR‑222 in the cancer stroma is associated with malignant potential in colorectal cancer.

Iida M, Hazama S, Tsunedomi R, Tanaka H, Takenouchi H, Kanekiyo S, Tokumitsu Y, Tomochika S, Tokuhisa Y, Sakamoto K, Suzuki N, Takeda S, Ueno T, Yamamoto S, Yoshino S, Fujita K, Kuroda M, Nagano H.

Oncol Rep. 2018 Jul 13. doi: 10.3892/or.2018.6575. [Epub ahead of print]

PMID:
30015977
2.

Current status of immunotherapy against gastrointestinal cancers and its biomarkers: Perspective for precision immunotherapy.

Hazama S, Tamada K, Yamaguchi Y, Kawakami Y, Nagano H.

Ann Gastroenterol Surg. 2018 Jun 22;2(4):289-303. doi: 10.1002/ags3.12180. eCollection 2018 Jul. Review.

3.

Local control of sphincter-preserving procedures and abdominoperineal resection for locally advanced low rectal cancer: Propensity score matched analysis.

Okamura R, Hida K, Yamaguchi T, Akagi T, Konishi T, Yamamoto M, Ota M, Matoba S, Bando H, Goto S, Sakai Y, Watanabe M; Japan Society of Laparoscopic Colorectal Surgery, Watanabe K, Otsuka K, Takemasa I, Tanaka K, Ikeda M, Matsuda C, Fukuda M, Hasegawa J, Akamoto S, Shiozawa M, Tsuruta A, Akiyoshi T, Kato T, Tsukamoto S, Ito M, Naito M, Kanazawa A, Takahashi T, Ueki T, Hayashi Y, Morita S, Yamaguchi T, Nakanishi M, Hasegawa H, Okamoto K, Teraishi F, Sumi Y, Tashiro J, Yatsuoka T, Nishimura Y, Okita K, Kobatake T, Horie H, Miyakura Y, Ro H, Nagakari K, Hidaka E, Umemoto T, Nishigori H, Murata K, Wakayama F, Makizumi R, Fujii S, Sunami E, Kobayashi H, Nakagawa R, Enomoto T, Ohnuma S, Higashijima J, Ozawa H, Ashida K, Fujita F, Uehara K, Maruyama S, Ohyama M, Yamamoto S, Hinoi T, Yoshimitsu M, Okajima M, Tanimura S, Kawasaki M, Ide Y, Hazama S, Watanabe J, Inagaki D, Toyokawa A.

Ann Gastroenterol Surg. 2017 Aug 14;1(3):199-207. doi: 10.1002/ags3.12032. eCollection 2017 Sep.

4.

pH-Dependent exhibition of hemolytic activity by an extract of Hypsizygus marmoreus fruiting bodies.

Saito K, Hazama S, Oda Y, Nakata M.

Biosci Trends. 2018 Jul 17;12(3):325-329. doi: 10.5582/bst.2018.01108. Epub 2018 May 29.

5.

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.

Pagès F, Mlecnik B, Marliot F, Bindea G, Ou FS, Bifulco C, Lugli A, Zlobec I, Rau TT, Berger MD, Nagtegaal ID, Vink-Börger E, Hartmann A, Geppert C, Kolwelter J, Merkel S, Grützmann R, Van den Eynde M, Jouret-Mourin A, Kartheuser A, Léonard D, Remue C, Wang JY, Bavi P, Roehrl MHA, Ohashi PS, Nguyen LT, Han S, MacGregor HL, Hafezi-Bakhtiari S, Wouters BG, Masucci GV, Andersson EK, Zavadova E, Vocka M, Spacek J, Petruzelka L, Konopasek B, Dundr P, Skalova H, Nemejcova K, Botti G, Tatangelo F, Delrio P, Ciliberto G, Maio M, Laghi L, Grizzi F, Fredriksen T, Buttard B, Angelova M, Vasaturo A, Maby P, Church SE, Angell HK, Lafontaine L, Bruni D, El Sissy C, Haicheur N, Kirilovsky A, Berger A, Lagorce C, Meyers JP, Paustian C, Feng Z, Ballesteros-Merino C, Dijkstra J, van de Water C, van Lent-van Vliet S, Knijn N, Mușină AM, Scripcariu DV, Popivanova B, Xu M, Fujita T, Hazama S, Suzuki N, Nagano H, Okuno K, Torigoe T, Sato N, Furuhata T, Takemasa I, Itoh K, Patel PS, Vora HH, Shah B, Patel JB, Rajvik KN, Pandya SJ, Shukla SN, Wang Y, Zhang G, Kawakami Y, Marincola FM, Ascierto PA, Sargent DJ, Fox BA, Galon J.

Lancet. 2018 May 26;391(10135):2128-2139. doi: 10.1016/S0140-6736(18)30789-X. Epub 2018 May 10.

PMID:
29754777
6.

Pharmacogenetics-based area-under-curve model can predict efficacy and adverse events from axitinib in individual patients with advanced renal cell carcinoma.

Yamamoto Y, Tsunedomi R, Fujita Y, Otori T, Ohba M, Kawai Y, Hirata H, Matsumoto H, Haginaka J, Suzuki S, Dahiya R, Hamamoto Y, Matsuyama K, Hazama S, Nagano H, Matsuyama H.

Oncotarget. 2018 Mar 30;9(24):17160-17170. doi: 10.18632/oncotarget.24715. eCollection 2018 Mar 30.

7.

Hedgehog Signals Mediate Anti-Cancer Drug Resistance in Three-Dimensional Primary Colorectal Cancer Organoid Culture.

Usui T, Sakurai M, Umata K, Elbadawy M, Ohama T, Yamawaki H, Hazama S, Takenouchi H, Nakajima M, Tsunedomi R, Suzuki N, Nagano H, Sato K, Kaneda M, Sasaki K.

Int J Mol Sci. 2018 Apr 6;19(4). pii: E1098. doi: 10.3390/ijms19041098.

8.

Survival benefit of lymph node dissection in surgery for colon cancer in elderly patients: A multicenter propensity score-matched study in Japan.

Takahashi M, Niitsu H, Sakamoto K, Hinoi T, Hattori M, Goto M, Bando H, Hazama S, Maeda K, Okita K, Horie H, Watanabe M; Japan Society of Laparoscopic Colorectal Surgery.

Asian J Endosc Surg. 2018 Mar 30. doi: 10.1111/ases.12474. [Epub ahead of print]

PMID:
29601663
9.

TROY is a promising prognostic biomarker in patients with colorectal cancer.

Nishioka M, Suehiro Y, Sakai K, Matsumoto T, Okayama N, Mizuno H, Ueno K, Suzuki N, Hashimoto S, Takami T, Hazama S, Nagano H, Sakaida I, Yamasaki T.

Oncol Lett. 2018 Apr;15(4):5989-5994. doi: 10.3892/ol.2018.8079. Epub 2018 Feb 16.

10.

Multicenter, phase II clinical trial of peptide vaccination with oral chemotherapy following curative resection for stage III colorectal cancer.

Kawamura J, Sugiura F, Sukegawa Y, Yoshioka Y, Hida JI, Hazama S, Okuno K.

Oncol Lett. 2018 Apr;15(4):4241-4247. doi: 10.3892/ol.2018.7905. Epub 2018 Jan 29.

11.

IgG response to MHC class I epitope peptides is a quantitative predictive biomarker in the early course of treatment of colorectal cancer using therapeutic peptides.

Kanekiyo S, Hazama S, Takenouchi H, Nakajima M, Shindo Y, Matsui H, Tokumitsu Y, Tomochika S, Tsunedomi R, Tokuhisa Y, Iida M, Sakamoto K, Suzuki N, Takeda S, Yamamoto S, Yoshino S, Okuno K, Udaka K, Kawakami Y, Matsueda S, Ito K, Nagano H.

Oncol Rep. 2018 May;39(5):2385-2392. doi: 10.3892/or.2018.6288. Epub 2018 Mar 1.

PMID:
29498403
12.

Cytotoxic T lymphocyte response to peptide vaccination predicts survival in stage III colorectal cancer.

Kawamura J, Sugiura F, Sukegawa Y, Yoshioka Y, Hida JI, Hazama S, Okuno K.

Cancer Sci. 2018 May;109(5):1545-1551. doi: 10.1111/cas.13547. Epub 2018 Mar 31.

13.

Metastatic ability and the epithelial-mesenchymal transition in induced cancer stem-like hepatoma cells.

Nishiyama M, Tsunedomi R, Yoshimura K, Hashimoto N, Matsukuma S, Ogihara H, Kanekiyo S, Iida M, Sakamoto K, Suzuki N, Takeda S, Yamamoto S, Yoshino S, Ueno T, Hamamoto Y, Hazama S, Nagano H.

Cancer Sci. 2018 Apr;109(4):1101-1109. doi: 10.1111/cas.13527. Epub 2018 Mar 6.

14.

High secreted protein acidic and rich in cysteine expression in peritumoral fibroblasts predicts better prognosis in patients with resectable gastric cancer.

Nakajima M, Yoshino S, Kanekiyo S, Maeda N, Sakamoto K, Tsunedomi R, Suzuki N, Takeda S, Yamamoto S, Hazama S, Hoshii Y, Oga A, Itoh H, Ueno T, Nagano H.

Oncol Lett. 2018 Jan;15(1):803-812. doi: 10.3892/ol.2017.7418. Epub 2017 Nov 15.

15.

[A Case of Intrahepatic Cholangiocarcinoma with Ductal Plate Malformation Pattern].

Sekiya M, Sakamoto K, Matsukuma S, Tokuhisa Y, Tokumitsu Y, Matsui H, Kanekiyo S, Tomochika S, Iida M, Takeda S, Suzuki N, Yoshino S, Hazama S, Hoshii Y, Nagano H.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1877-1879. Japanese.

PMID:
29394806
16.

[A Case of Colorectal Cancer with Peritoneal Dissemination and Liver Metastasis That Responded to Comprehensive Treatment by Chemotherapy and CRS plus HIPEC].

Fujimoto T, Suzuki N, Tomochika S, Tanaka H, Matsui H, Sakamoto K, Takeda S, Yamamoto S, Yoshino S, Hazama S, Ishibashi H, Yonemura Y, Ueno T, Nagano H.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1704-1707. Japanese.

PMID:
29394749
17.

[Two Cases of Laparoscopic Simultaneous Resection for Synchronous Liver Metastasis of Colon Cancer].

Tomochika S, Suzuki N, Tanaka H, Inoue Y, Tokumitsu Y, Kanekiyo S, Tokuhisa Y, Iida K, Sakamoto K, Takeda S, Yamamoto S, Yoshino S, Hazama S, Ueno T, Nagano H.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1278-1280. Japanese.

PMID:
29394606
18.

[A Case of Conversion Surgery for Unresectable Colorectal Liver Metastases, Following Effective Combined Chemotherapy with Molecular Targeting Agents].

Nakashima C, Suzuki N, Tomochika S, Tanaka H, Tokumitsu Y, Kanekiyo S, Tokuhisa Y, Iida M, Sakamoto K, Takeda S, Yamamoto S, Yoshino S, Hazama S, Ueno T, Nagano H.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1272-1274. Japanese.

PMID:
29394604
19.

[A Difficult Diagnostic Case of Pancreatic Acinar Cell Carcinoma].

Matsui H, Sakamoto K, Matsukuma S, Tokumitsu Y, Tokuhisa Y, Kanekiyo S, Tomochika S, Iida M, Suzuki N, Takeda S, Yoshino S, Hazama S, Ueno T, Nagano H.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1235-1237. Japanese.

PMID:
29394592
20.

Expression levels of UL16 binding protein 1 and natural killer group 2 member D affect overall survival in patients with gastric cancer following gastrectomy.

Kamei R, Yoshimura K, Yoshino S, Inoue M, Asao T, Fuse M, Wada S, Kuramasu A, Furuya-Kondo T, Oga A, Iizuka N, Suzuki N, Maeda N, Watanabe Y, Matsukuma S, Iida M, Takeda S, Ueno T, Yamamoto N, Fukagawa T, Katai H, Sasaki H, Hazama S, Oka M, Nagano H.

Oncol Lett. 2018 Jan;15(1):747-754. doi: 10.3892/ol.2017.7354. Epub 2017 Nov 6.

21.

[Three Cases of Obstructive Left-Sided Colon Cancer Resected by Laparoscopic Surgery].

Yamada K, Suzuki N, Tomochika S, Tanaka H, Tokumitsu Y, Kanekiyo S, Tokuhisa Y, Iida M, Sakamoto K, Takeda S, Yamamoto S, Yoshino S, Hazama S, Ueno T, Nagano H.

Gan To Kagaku Ryoho. 2018 Jan;45(1):109-111. Japanese.

PMID:
29362324
22.

Stemness Is Enhanced in Gastric Cancer by a SET/PP2A/E2F1 Axis.

Enjoji S, Yabe R, Tsuji S, Yoshimura K, Kawasaki H, Sakurai M, Sakai Y, Takenouchi H, Yoshino S, Hazama S, Nagano H, Oshima H, Oshima M, Vitek MP, Matsuura T, Hippo Y, Usui T, Ohama T, Sato K.

Mol Cancer Res. 2018 Mar;16(3):554-563. doi: 10.1158/1541-7786.MCR-17-0393. Epub 2018 Jan 12.

PMID:
29330298
23.

Low invasiveness of thoracoscopic esophagectomy in the prone position for esophageal cancer: a propensity score-matched comparison of operative approaches between thoracoscopic and open esophagectomy.

Kanekiyo S, Takeda S, Tsutsui M, Nishiyama M, Kitahara M, Shindo Y, Tokumitsu Y, Tomochika S, Tokuhisa Y, Iida M, Sakamoto K, Suzuki N, Yamamoto S, Yoshino S, Hazama S, Ueno T, Nagano H.

Surg Endosc. 2018 Apr;32(4):1945-1953. doi: 10.1007/s00464-017-5888-z. Epub 2017 Oct 26.

PMID:
29075967
24.

Aortic valve replacement in small patients.

Hisata Y, Yokose S, Hazama S, Matsumaru I, Eishi K.

Asian J Surg. 2017 Oct 11. pii: S1015-9584(17)30339-1. doi: 10.1016/j.asjsur.2017.08.005. [Epub ahead of print]

25.

miR-125b-1 and miR-378a are predictive biomarkers for the efficacy of vaccine treatment against colorectal cancer.

Tanaka H, Hazama S, Iida M, Tsunedomi R, Takenouchi H, Nakajima M, Tokumitsu Y, Kanekiyo S, Shindo Y, Tomochika S, Tokuhisa Y, Sakamoto K, Suzuki N, Takeda S, Yamamoto S, Yoshino S, Ueno T, Hamamoto Y, Fujita Y, Tanaka H, Tahara K, Shimizu R, Okuno K, Fujita K, Kuroda M, Nakamura Y, Nagano H.

Cancer Sci. 2017 Nov;108(11):2229-2238. doi: 10.1111/cas.13390. Epub 2017 Sep 22.

26.

Fusobacterium nucleatum as a prognostic marker of colorectal cancer in a Japanese population.

Yamaoka Y, Suehiro Y, Hashimoto S, Hoshida T, Fujimoto M, Watanabe M, Imanaga D, Sakai K, Matsumoto T, Nishioka M, Takami T, Suzuki N, Hazama S, Nagano H, Sakaida I, Yamasaki T.

J Gastroenterol. 2018 Apr;53(4):517-524. doi: 10.1007/s00535-017-1382-6. Epub 2017 Aug 19.

PMID:
28823057
27.

miR-196b, miR-378a and miR-486 are predictive biomarkers for the efficacy of vaccine treatment in colorectal cancer.

Shindo Y, Hazama S, Nakamura Y, Inoue Y, Kanekiyo S, Suzuki N, Takenouchi H, Tsunedomi R, Nakajima M, Ueno T, Takeda S, Yoshino S, Okuno K, Fujita Y, Hamamoto Y, Kawakami Y, Oka M, Nagano H.

Oncol Lett. 2017 Aug;14(2):1355-1362. doi: 10.3892/ol.2017.6303. Epub 2017 Jun 2.

28.

Correlation Between NKG2DL Expression and Antitumor Effect of Protein-bound Polysaccharide-K in Tumor-bearing Mouse Models.

Konagai A, Yoshimura K, Hazama S, Yamamoto N, Aoki K, Ueno T, Fujioka M, Iijima H, Kato M, Uchida M, Wada T, Inoue M, Asao T, Fuse M, Wada S, Kuramasu A, Kamei R, Takeda S, Yamamoto S, Yoshino S, Oka M, Nagano H.

Anticancer Res. 2017 Aug;37(8):4093-4101.

PMID:
28739693
29.

Postoperative Adjuvant Therapy for Resectable Pancreatic Cancer With Gemcitabine and Adoptive Immunotherapy.

Matsui H, Hazama S, Sakamoto K, Shindo Y, Kanekiyo S, Nakashima M, Matsukuma S, Tokuhisa Y, Iida M, Suzuki N, Yoshimura K, Takeda S, Ueno T, Yoshino S, Oka M, Nagano H.

Pancreas. 2017 Sep;46(8):994-1002. doi: 10.1097/MPA.0000000000000880.

30.

Integrative analysis of genomic alterations in triple-negative breast cancer in association with homologous recombination deficiency.

Kawazu M, Kojima S, Ueno T, Totoki Y, Nakamura H, Kunita A, Qu W, Yoshimura J, Soda M, Yasuda T, Hama N, Saito-Adachi M, Sato K, Kohsaka S, Sai E, Ikemura M, Yamamoto S, Ogawa T, Fukayama M, Tada K, Seto Y, Morishita S, Hazama S, Shibata T, Yamashita Y, Mano H.

PLoS Genet. 2017 Jun 21;13(6):e1006853. doi: 10.1371/journal.pgen.1006853. eCollection 2017 Jun.

31.

Erratum to: Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer.

Suto T, Ishiguro M, Hamada C, Kunieda K, Masuko H, Kondo K, Ishida H, Nishimura G, Sasaki K, Morita T, Hazama S, Maeda K, Mishima H, Ike H, Sadahiro S, Sugihara K, Okajima M, Saji S, Sakamoto J, Tomita N.

Int J Clin Oncol. 2017 Aug;22(4):805-806. doi: 10.1007/s10147-017-1146-6. No abstract available.

PMID:
28608229
32.

Rapid and sensitive detection of UGT1A1 polymorphisms associated with irinotecan toxicity by a novel DNA microarray.

Tsunedomi R, Hazama S, Okayama N, Oka M, Nagano H.

Cancer Sci. 2017 Jul;108(7):1504-1509. doi: 10.1111/cas.13272. Epub 2017 Jun 5.

33.

A phase II, multicenter, single-arm study of tri-weekly low-dose nanoparticle albumin-bound paclitaxel chemotherapy for patients with metastatic or recurrent breast cancer.

Yamamoto S, Maeda N, Nagashima Y, Kubo H, Sato Y, Matsui H, Inoue Y, Shindo Y, Kanekiyo S, Sakamoto K, Suzuki N, Takeda S, Ueno T, Yoshino S, Hazama S, Oka M, Nagano H.

Breast Cancer. 2017 Nov;24(6):783-789. doi: 10.1007/s12282-017-0779-7. Epub 2017 Apr 24.

PMID:
28439763
34.

Predictive biomarkers for the efficacy of peptide vaccine treatment: based on the results of a phase II study on advanced pancreatic cancer.

Shindo Y, Hazama S, Suzuki N, Iguchi H, Uesugi K, Tanaka H, Aruga A, Hatori T, Ishizaki H, Umeda Y, Fujiwara T, Ikemoto T, Shimada M, Yoshimatsu K, Takenouchi H, Matsui H, Kanekiyo S, Iida M, Koki Y, Arima H, Furukawa H, Ueno T, Yoshino S, Fujita T, Kawakami Y, Nakamura Y, Oka M, Nagano H.

J Exp Clin Cancer Res. 2017 Feb 28;36(1):36. doi: 10.1186/s13046-017-0509-1.

35.

[Long-Term Survival of a Patient with Recurrent Duodenal GIST Treated with Various Molecular Targeted Drugs and TAE - A Case Report].

Chidimatsu H, Matsui H, Iida M, Kanekiyo S, Tokumitsu Y, Tokuhisa Y, Sakamoto K, Suzuki N, Takeda S, Ueno T, Yamamoto S, Yoshino S, Hazama S, Nagano H.

Gan To Kagaku Ryoho. 2016 Nov;43(12):2362-2364. Japanese.

PMID:
28133322
36.

[A Case of Ascending Colon Cancer with Extensive Abdominal Wall Abscess].

Kuwahara T, Tokuhisa Y, Suzuki N, Tomochika S, Inoue Y, Tanaka H, Nishiyama M, Kanekiyo S, Iida M, Sakamoto K, Takeda S, Ueno T, Yoshino S, Hazama S, Nagano H.

Gan To Kagaku Ryoho. 2016 Nov;43(12):2341-2343. Japanese.

PMID:
28133315
37.

[A Case of Esophageal Submucosal Tumor Undiagnosed Preoperatively and Treated with Thoracoscopic Enucleation].

Tokuhisa A, Takeda S, Kanekiyo S, Nishiyama M, Kitahara M, Iida M, Sakamoto K, Suzuki N, Ueno T, Yamamoto S, Yoshino S, Hazama S, Nagano H.

Gan To Kagaku Ryoho. 2016 Nov;43(12):2175-2177. Japanese.

PMID:
28133260
38.

[A Case of Heterochronic Cervical Esophageal Cancer with a Subcutaneous Abscess Showing a Complete Response to Chemoradiation Therapy].

Nishiyama M, Takeda S, Kanekiyo S, Iida M, Kitahara M, Tokumitsu Y, Tomochika S, Tokuhisa Y, Sakamoto K, Suzuki N, Ueno T, Yamamoto S, Yoshino S, Hazama S, Nagano H.

Gan To Kagaku Ryoho. 2016 Nov;43(12):2004-2006. Japanese.

PMID:
28133203
39.

[A Case of Borderline Resectable Pancreatic Cancer Responding to Preoperative GEM plus Nab-PTX Combination Chemotherapy].

Fujimoto T, Ueno T, Sakamoto K, Matsukuma S, Matsui H, Shindo Y, Tokumitsu Y, Kanekiyo S, Iida M, Tokuhisa Y, Suzuki N, Takeda S, Yoshino S, Hazama S, Nagano H.

Gan To Kagaku Ryoho. 2016 Nov;43(12):1978-1981. Japanese.

PMID:
28133195
40.

[Use of a Posterior Thigh Flap with the Gluteus Maximus for Perineal Reconstruction - A Case of Fournier's Gangrene with Rectal Cancer].

Tanaka H, Suzuki N, Tomochika S, Inoue Y, Kuwahara T, Sakamoto K, Takeda S, Ueno T, Yamamoto S, Okita T, Yoshimoto S, Yoshino S, Hazama S, Mutou M, Nagano H.

Gan To Kagaku Ryoho. 2016 Nov;43(12):1821-1823. Review. Japanese.

PMID:
28133143
41.

[Two Cases of Primary Hepatic Mucosa-Associated Lymphoid Tissue(MALT) Lymphoma].

Fujiwara Y, Sakamoto K, Tokuhisa Y, Tokumitsu Y, Nakajima M, Matsukuma S, Matsui H, Shindo Y, Kanekiyo S, Suzuki N, Takeda S, Ueno T, Yoshino S, Hazama S, Nagano H.

Gan To Kagaku Ryoho. 2016 Nov;43(12):1794-1796. Japanese.

PMID:
28133134
42.

[Unresectable Stage IV Sigmoid Colon Cancer with Extended Resection for Primary Tumor - A Case Report].

Kimura Y, Suzuki N, Tomochika S, Inoue Y, Tanaka H, Tokuhisa Y, Iida M, Sakamoto K, Takeda S, Ueno T, Yamamoto S, Yoshino S, Hazama S, Nagano H.

Gan To Kagaku Ryoho. 2016 Nov;43(12):1724-1726. Japanese.

PMID:
28133111
43.

Association of tumor necrosis factor-α polymorphism with chemotherapy-induced oral mucositis in patients with esophageal cancer.

Sakamoto K, Takeda S, Kanekiyo S, Nishiyama M, Kitahara M, Ueno T, Yamamoto S, Yoshino S, Hazama S, Okayama N, Nagano H.

Mol Clin Oncol. 2017 Jan;6(1):125-129. doi: 10.3892/mco.2016.1081. Epub 2016 Nov 14.

44.

Establishment of a Novel Model for Anticancer Drug Resistance in Three-Dimensional Primary Culture of Tumor Microenvironment.

Usui T, Sakurai M, Enjoji S, Kawasaki H, Umata K, Ohama T, Fujiwara N, Yabe R, Tsuji S, Yamawaki H, Hazama S, Takenouchi H, Nakajima M, Tsunedomi R, Suzuki N, Nagano H, Sato K.

Stem Cells Int. 2016;2016:7053872. doi: 10.1155/2016/7053872. Epub 2016 Dec 29.

45.

Highly sensitive faecal DNA testing of TWIST1 methylation in combination with faecal immunochemical test for haemoglobin is a promising marker for detection of colorectal neoplasia.

Suehiro Y, Zhang Y, Hashimoto S, Takami T, Higaki S, Shindo Y, Suzuki N, Hazama S, Oka M, Nagano H, Sakaida I, Yamasaki T.

Ann Clin Biochem. 2018 Jan;55(1):59-68. doi: 10.1177/0004563217691064. Epub 2017 Jan 12.

PMID:
28081635
46.

Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer.

Suto T, Ishiguro M, Hamada C, Kunieda K, Masuko H, Kondo K, Ishida H, Nishimura G, Sasaki K, Morita T, Hazama S, Maeda K, Mishima H, Ike H, Sadahiro S, Sugihara K, Okajima M, Saji S, Sakamoto J, Tomita N.

Int J Clin Oncol. 2017 Jun;22(3):494-504. doi: 10.1007/s10147-016-1083-9. Epub 2017 Jan 11. Erratum in: Int J Clin Oncol. 2017 Aug;22(4):805-806.

47.

Cetuximab strongly enhances immune cell infiltration into liver metastatic sites in colorectal cancer.

Inoue Y, Hazama S, Suzuki N, Tokumitsu Y, Kanekiyo S, Tomochika S, Tsunedomi R, Tokuhisa Y, Iida M, Sakamoto K, Takeda S, Ueno T, Yoshino S, Nagano H.

Cancer Sci. 2017 Mar;108(3):455-460. doi: 10.1111/cas.13162.

48.

MicroRNA-6826 and -6875 in plasma are valuable non‑invasive biomarkers that predict the efficacy of vaccine treatment against metastatic colorectal cancer.

Kijima T, Hazama S, Tsunedomi R, Tanaka H, Takenouchi H, Kanekiyo S, Inoue Y, Nakashima M, Iida M, Sakamoto K, Suzuki N, Takeda S, Ueno T, Yamamoto S, Yoshino S, Okuno K, Nagano H.

Oncol Rep. 2017 Jan;37(1):23-30. doi: 10.3892/or.2016.5267. Epub 2016 Nov 22.

49.

Phase II clinical trial of peptide cocktail therapy for patients with advanced pancreatic cancer: VENUS-PC study.

Suzuki N, Hazama S, Iguchi H, Uesugi K, Tanaka H, Hirakawa K, Aruga A, Hatori T, Ishizaki H, Umeda Y, Fujiwara T, Ikemoto T, Shimada M, Yoshimatsu K, Shimizu R, Hayashi H, Sakata K, Takenouchi H, Matsui H, Shindo Y, Iida M, Koki Y, Arima H, Furukawa H, Ueno T, Yoshino S, Nakamura Y, Oka M, Nagano H.

Cancer Sci. 2017 Jan;108(1):73-80. doi: 10.1111/cas.13113. Epub 2016 Dec 19.

50.

Prediction of the efficacy of immunotherapy by measuring the integrity of cell-free DNA in plasma in colorectal cancer.

Kitahara M, Hazama S, Tsunedomi R, Takenouchi H, Kanekiyo S, Inoue Y, Nakajima M, Tomochika S, Tokuhisa Y, Iida M, Sakamoto K, Suzuki N, Takeda S, Ueno T, Yamamoto S, Yoshino S, Nagano H.

Cancer Sci. 2016 Dec;107(12):1825-1829. doi: 10.1111/cas.13085. Epub 2016 Dec 18.

Supplemental Content

Loading ...
Support Center